Berkshire Sterile Manufacturing Inc. will buy and renovate portions of a 116,000-square-foot building in Lee with assistance from a MassDevelopment bond.

MassDevelopment has issued a $4.08 million bond on behalf of the biopharmaceutical startup. MassDevelopment also offered mortgage and equipment insurance guarantees. Berkshire Bank purchased the bond.

Renovation plans for a new manufacturing facility include clean rooms, labs and work rooms for product formulation, final inspection and packaging. The company will also use bond proceeds to buy and install new drug manufacturing equipment.

"Through our financing programs, MassMEC, and the AMP it up! campaign, MassDevelopment is committed to supporting growth in the manufacturing sector in Massachusetts, and projects such as Berkshire Sterile Manufacturing’s new facility in Lee help us accomplish that goal," MassDevelopment President and CEO Marty Jones said in a statement. "This bond will help Berkshire Sterile create manufacturing job opportunities to the Berkshire region and bolster the commonwealth’s biopharmaceutical manufacturing sector." 

Berkshire Sterile Manufacturing plans to focus on contract manufacturing sterile drugs in the pre-clinical and clinical phases for pharmaceutical, biotech, and medical device companies at its new facility.